Literature DB >> 20816670

A novel approach for stress-induced gastritis based on paradoxical anti-oxidative and anti-inflammatory action of exogenous 8-hydroxydeoxyguanosine.

Chan Young Ock1, Kyung Sook Hong, Ki-Seok Choi, Myung-Hee Chung, Yun soo Kim, Ju Hyun Kim, Ki-Baik Hahm.   

Abstract

Reactive oxygen species (ROS) attack guanine bases in DNA and form 8-hydroxydeoxyguanosine (8-OHdG), which has been regarded simply as an oxidative mutagenic by-product. On the other hand, our previous report showed paradoxically ROS attenuating action of generated 8-OHdG. In the current study, both in vitro and in vivo experiments were executed in order to document anti-oxidative and anti-inflammatory actions of 8-OHdG in cell model and to elucidate the therapeutic efficacy against water immersion restraint stress (WIRS)-induced gastritis animal model. Electron spin resonance measurements showed that 8-OHdG at >5μg/ml completely scavenged OH(-) radicals, which was further confirmed by checking 2'-7'-dichlorodihydrofluorescein diacetate (DCFDA) spectroscopy. On molecular assay, 8-OHdG antagonized the action of GTP on Rac, a small GTP binding protein, without affecting Rac-guanosine exchange factor (GEF) or phosphoinositide 3-kinases (PI3K) activity. In Raw264.7 cells, 8-OHdG was found to be associated with marked attenuations of NOX1, NOXO1, and NOXA1 accompanied with the decreased expressions of LPS-induced inflammatory mediators including COX-2, iNOS, IL-1β, and IL-6. Similarly, 8-OHdG attenuated hypoxia-induced angiogenesis and platelet endothelial cell adhesion molecule-1 (PECAM-1), COX-2, iNOS, IL-8, and VEGF expressions in HUVEC cells. At transcriptional level, 8-OHdG inhibited the nuclear translocation of NF-κB, inhibitory κB kinase (IKK) β kinase activation, and decreased phospho-IκBα levels. 8-OHdG efficiently ameliorated WIRS-induced gastric mucosal injury as evidenced with improvement of gross lesion index and attenuation of engaging mediators. Taken together, exogenous 8-OHdG can be a functional molecule regulating oxidative stress-induced gastritis through either antagonizing Rac-GTP binding or blocking the signals responsible for gastric inflammatory cascade.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816670     DOI: 10.1016/j.bcp.2010.08.023

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

Review 1.  8-Hydroxydeoxyguanosine: not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal diseases.

Authors:  Chan-Young Ock; Eun-Hee Kim; Duck Joo Choi; Ho Jae Lee; Ki-Baik Hahm; Myung Hee Chung
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

2.  8-Hydroxy-2-deoxyguanosine prevents plaque formation and inhibits vascular smooth muscle cell activation through Rac1 inactivation.

Authors:  Joo Young Huh; Dong Ju Son; Yoonji Lee; Junghyun Lee; Boyeon Kim; Hwan Myung Lee; Hanjoong Jo; Sun Choi; Hunjoo Ha; Myung-Hee Chung
Journal:  Free Radic Biol Med       Date:  2012-04-19       Impact factor: 7.376

3.  Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma.

Authors:  Ryujiro Akaishi; Fumiyoshi Fujishima; Hirotaka Ishida; Junichi Tsunokake; Takuro Yamauchi; Yusuke Gokon; Shunsuke Ueki; Toshiaki Fukutomi; Hiroshi Okamoto; Kai Takaya; Chiaki Sato; Yusuke Taniyama; Tomohiro Nakamura; Naoki Nakaya; Takashi Kamei; Hironobu Sasano
Journal:  Esophagus       Date:  2022-01-08       Impact factor: 3.671

4.  Investigating the Anti-Inflammatory Effects of RCI001 for Treating Ocular Surface Diseases: Insight Into the Mechanism of Action.

Authors:  Seunghoon Kim; Ye Won Jang; Young-Ah Ku; Yungyeong Shin; Md Mahbubur Rahman; Myung-Hee Chung; Yong Ho Kim; Dong Hyun Kim
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

5.  HO-1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy.

Authors:  Ryujiro Akaishi; Fumiyoshi Fujishima; Hirotaka Ishida; Junichi Tsunokake; Takuro Yamauchi; Yusuke Gokon; Shunsuke Ueki; Toshiaki Fukutomi; Hiroshi Okamoto; Kai Takaya; Chiaki Sato; Yusuke Taniyama; Tomohiro Nakamura; Naoki Nakaya; Takashi Kamei; Hironobu Sasano
Journal:  Cancer Rep (Hoboken)       Date:  2021-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.